The use of brain-affecting drugs such as opioids, antidepressants, tranquilizers and antipsychotics in seniors has almost doubled in a decade and the trend will likely continue upward according to data from U.S. Centers for Disease Control and Prevention. A new study from the University of
In a recent report from Centers for Medicare & Medicaid Services (CMS) News, almost 12 million Medicare beneficiaries received an average of $2,272 in discounts per person totaling over $26.8 billion since the inception of the Affordable Care Act in 2010. Acting Administrator for CMS,
With up to 40% of your Star Ratings attributed to medication-related quality measures, join us for an information-packed 30-minute webinar. Thursday, March 2, 2017 12:00 PM – 12:30 PM CST Discover how to incorporate smart analytics, member acuity and member outreach prioritization techniques to guarantee a
The Challenge Health plans and PBMs are facing the highest CMR completion rate hike to obtain a 5-star rating in 2017. CMS has set the table for plans and PBMs to focus on health outcomes – driving MTM services towards being the level of pharmacy –
One fact we can safely predict in 2017, is that value-based care models are not going anywhere. For insurers and practitioners to successfully navigate these new models is to focus on these four key areas: population health and disease management, clinical decision support technology, care
Opioid abuse continues to rise in the United States, affecting not only the individual – but also their family, friends, employers, and communities. According to the Centers for Disease Control and Prevention, nearly 2 million Americans currently abuse prescription opioids, causing an estimated 44 people to die every day, tallying an unthinkable 16,000 opioid related deaths each year. Furthermore, this number does not account for the individuals that move on from prescription drugs to more dangerous street drugs that so often times result in additional overdoses and deaths.